Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Study of microRNA associated with metformin?s anti-tumor effect [pancreatic cancer]

ABSTRACT: The miRNAs expression was markedly altered with the treatment of metformin in vitro and in vivo and various miRNAs induced by metformin also may contribute to tumor regression in vitro and in vivo. Using a custom microarray platform, we analyzed the expression levels of 1042 human miRNA probes in the cell lines in vitro and tumorous tissues in vivo that were treated with and without metformin.

ORGANISM(S): Homo sapiens

SUBMITTER: Kondo Satoshi

PROVIDER: S-ECPF-GEOD-37406 | biostudies-other |

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Study of microRNA associated with metformin’s anti-tumor effect [pancreatic cancer]

2013-06-01 | GSE37406 | GEO

Study of microRNA associated with metforminM-bM-^@M-^Ys anti-tumor effect [pancreatic cancer]

Project description:The miRNAs expression was markedly altered with the treatment of metformin in vitro and in vivo and various miRNAs induced by metformin also may contribute to tumor regression in vitro and in vivo. Using a custom microarray platform, we analyzed the expression levels of 1042 human miRNA probes in the cell lines in vitro and tumorous tissues in vivo that were treated with and without metformin.

2013-06-01 | E-GEOD-37406 | biostudies-arrayexpress

Study of microRNA associated with gemcitabine’s anti-tumor effect

Project description:The miRNAs expression was markedly altered with the treatment of gemcitabine on human CCC cells in vitro. And various miRNAs induced by gemcitabine may contribute to tumor regression in vitro . Using a custom microarray platform, we analyzed the expression levels of 1042 human miRNA probes in the cell lines in vitro that were treated with and without gemcitabine.

2015-09-15 | E-GEOD-55676 | biostudies-arrayexpress

Study of microRNA associated with metformin’s anti-tumor effect

2012-04-05 | GSE30289 | GEO

Study of microRNA associated with gemcitabine’s anti-tumor effect

2015-09-15 | GSE55676 | GEO

Study of microRNA associated with the anti-tumor effect of gemcitabine

Project description:The miRNAs expression was markedly altered with the treatment of gemcitabine on human CCC cells in vitro. And various miRNAs induced by gemcitabine may contribute to tumor regression in vitro. Using a custom microarray platform, we analyzed the expression levels of 2555 human miRNA probes in the cell lines in vitro that were treated with and without gemcitabine.

2016-04-01 | E-GEOD-67257 | biostudies-arrayexpress

Study of microRNA associated with the anti-tumor effect of gemcitabine

2016-04-01 | GSE67257 | GEO

Study of microRNA associated with metformin’s anti-tumor effect [Huh7 cells]

2015-03-01 | GSE44204 | GEO

Study of microRNA associated with metformin’s anti-tumor effect in cholangiocarcinoma

Project description:The miRNAs expression was markedly altered with the treatment of metformin in vivo and various miRNAs induced by metformin also may contribute to tumor growth of cholangiocarcinoma in vivo.

2016-09-01 | GSE71905 | GEO

Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.

Project description:Either metformin or liraglutide has been reported to have anti-tumor effects on pancreatic cancer cells. However, it is not clear whether their combined treatment has additive or synergistic anti-tumor effects on pancreatic cancer cells. In this study, the human pancreatic cancer cell line MiaPaca-2 was incubated with liraglutide and/or metformin. The cell Counting Kit-8 (CCK-8), colony formation, flow cytometry, and wound-healing and transwell migration assays were used to detect cell viability, clonogenic survival, cell cycle and cell migration, respectively. RT-PCR and western blot analyses were used to determine the mRNA and protein levels of related molecules. Results showed that combination treatment with liraglutide (100 nmol/L) and metformin (0.75 mmol/L) significantly decreased cell viability and colony formation, caused cell cycle arrest, upregulated the level of pro-apoptotic proteins Bax and cleaved caspase-3, and inhibited cell migration in the cells, although their single treatment did not exhibit such effects. Combination index value for cell viability indicated a synergistic interaction of liraglutide and metformin. Moreover, the combined treatment with liraglutide and metformin could activate the phosphorylation of AMP-activated protein kinase (AMPK) more potently than their single treatment in the cells. These results suggest that liraglutide in combination with metformin has a synergistic anti-tumor effect on the pancreatic cancer cells, which may be at least partly due to activation of AMPK signaling. Our study provides new insights into the treatment of patients with type 2 diabetes and pancreatic cancer.

| S-EPMC5999272 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data